Flash
›
Immunic, Inc. (IMUX) Deep Dive Video
Immunic, Inc. (IMUX) Deep Dive Video
Summary
A cash-constrained, late-stage MS biotech with a dual-mechanism “neuroprotection” swing—ENSURE Phase 3 data in 2026 determines whether IMUX becomes a multibillion-dollar contender or a liquidation story.
View IMUX stock page
·
Read the IMUX research report
Loading the video player…